- Advertising
- Asia
- Bangladesh
- Biological Inventions
- BRAND VALUATION
- China
- Comparative Advertisement
- Copyright
- Copyright Infringement
- Copyright Litigation
- Counterfeiting
- Covid
- Data Protection
- Design
- Digital Marketing Rights
- DRM
- Electronics
- Geographical Indication
- India
- Indian Patents Act
- Indonesia
- Intellectual Property
- Interim Injunction
- IP Commercialization
- IP Licensing
- IP Litigation
- IP Practice in India
- IPAB
- IPAB Decisions
- Japan
- Legal Issues
- Licensing
- Malaysia
- Myanmar
- NCLT
- NEPAL
- Net Neutrality
- News & Updates
- Office
- Patent Commercialisation
- Patent Cooperation Treaty
- patent infringement
- Patent Licensing
- Patent Litigation
- Patent Opposition
- Patent Prosecution
- Patent Rule Amendment
- Patent Term Extension
- Patents
- pharma
- Philippines
- Punitive Damages
- Section 3(D)
- section 64
- Singapore
- South-east Asia
- Technology
- Technology Transfer
- Thailand
- Trademark
- Trademark Litigation
- UAE
- Uncategorized
- USPTO
- Vietnam
- WIPO
Elli Lilly Enters into Licensing Deals with Indian Companies
Recently, Elli Lilly, a US-based major Pharmaceutical company, has entered into licensing agreements with a number of Indian drug manufacturers for the manufacture of and supply of Baricitinib in India which is showing promise as a drug for the treatment of Covid-19. The licensing agreement with Eli Lilly is voluntary, royalty-free, and non-exclusive in nature … Continue reading Elli Lilly Enters into Licensing Deals with Indian Companies
Read more »Practice Pointer: Form 27 Requirement in India (Statement Regarding the Working/Non-Working of Issued Patents)
It is needless to say that one core mandate of protecting one’s intellectual property is to promote the progress of science for the benefit of humankind. At the same time, it is also important to ensure that a patentee’s right of excluding others from making, selling, using, offering to sell, and importing the protected subject … Continue reading Practice Pointer: Form 27 Requirement in India (Statement Regarding the Working/Non-Working of Issued Patents)
Read more »Technology Transfer Opportunities for Pharma/Biotech/Diagnostic Companies in the SME Sector
IIPRD (IIPRD) is among the leading Indian IP Consulting Firms focusing on Technology Transfer and Licensing for numerous Indian and Global Corporates and Research Institutes. IIPRD is highly active in the Technology Transfer and Licensing of Patent Backed Technologies/IP’s in the domains of Pharmaceutical, Life Sciences, Diagnostics, Telecommunications, Software, and Medical Devices among others. IKP … Continue reading Technology Transfer Opportunities for Pharma/Biotech/Diagnostic Companies in the SME Sector
Read more »Natco Files India’s First Compulsory Licensing Application
September 14, 2011 - 4:38 am
Categories:
Patent Commercialisation
Pharma- biotech- Patent Commercialisation
0 Comments Natco Pharma has filed India’s first Compulsory Licensing (CL) Application (in accordance with Section 84(1) of the Indian Patents Act) against one of the Bayer’s patented drug Sorafenib, marketed by Bayer as Nexavar for treating Kidney and Liver Cancer. Patent on Sorafenib is granted in India on 03.03.2008 having number IN 215758. This will be … Continue reading Natco Files India’s First Compulsory Licensing Application
Read more »Inventors – All Technologies Are not Worth Billions
July 31, 2011 - 6:23 pm
Categories:
high-tech-patent-commercialisation
Patent Commercialisation
Pharma- biotech- Patent Commercialisation
0 Comments Working in the IP/Technology Commercialization and Out-Licensing domain makes you assess and evaluate the commercial viability of numerous IP backed inventions across technology domains. Apart from learning about and assessing new technologies, we also tend to learn quite a lot about Inventors’ mindset, specifically about their perspective of their own inventions. This article relates to … Continue reading Inventors – All Technologies Are not Worth Billions
Read more »Indian Granted Patends…Enforceable?
The Indian Patent Act, 2005, like for most other geographies, does accord to and follow the disclosure guidelines put forth by the TRIPS and has similar Patentability grounds, especially for non-Pharmaceutical subject matters, in which the contention over 3(d) leads to a different interpretation over efficacy grounds. Furthermore, special provisions such as those provided under … Continue reading Indian Granted Patends…Enforceable?
Read more »Internatioinal Patent Protection in Electronics & IT (SIP – EIT) Scheme by DIT
December 16, 2010 - 7:32 am
Categories:
high-tech-patent-commercialisation
Patent Commercialisation
0 Comments It is enriching to hear and read so much of focus going these days into Innovation at Grass Root and Startup level. With initiatives being taken at all levels by Stakeholders including FICCI, MSME, DIT, and NASSCOM, the next wave of the so-called Start-up innovation can really be envisioned. As has correctly been stated by … Continue reading Internatioinal Patent Protection in Electronics & IT (SIP – EIT) Scheme by DIT
Read more »Asian Electronics Ltd. vs. Havells India Ltd.
Working of the invention playing a role in deciding Balance of convenience This time Asian Electronics Ltd., referred to as Asian hereinafter, owner of the Indian Patent Application No. 193488 titled “Conversion Kit to change the fluorescent lighting units inductive operation to electronic operation” claimed injunction and consequential reliefs including damages against the Defendant, also … Continue reading Asian Electronics Ltd. vs. Havells India Ltd.
Read more »